Stock Research for OSIR

OSIR

Featured Broker: Ally Invest

Get the due diligence for another stock.

 

OSIR Stock Chart & Research Data

The OSIR chart settings shown below allow you to select time intervals of 1 min, 30 mins, an hour or by day - week - month. There is also the ability to change the OSIR chart style to candles, hollow candles, bars, lines or add various indicators. You can even add a symbol and compare history.


 


OSIR Due diligence Resources & Stock Charts

The OSIR stock resources shown below were gathered to cut back on time by allowing you to visit multiple sites at once. For your convenience each link clicked will open in a window. In addition to the individual links there is a button at the bottom that will allow you to open all the links at the same time. Note opening all links at once may not work with all browsers. Some browsers block multiple windows, to resolve this please allow that site to use pop-ups.

The Four Most Popular Resources

CNN View OSIR Detailed Price Forecast - CNN Money CNN View OSIR Detailed Summary - Google Finance
Yahoo View OSIR Detailed Summary - Yahoo! Finance Zacks View OSIR Stock Research & Analysis - Zacks.com


Stock Analysis

TradeIdeas View OSIR Trends & Analysis - Trade-Ideas Barrons View OSIR Major Holders - Barrons
NASDAQ View OSIR Call Transcripts - NASDAQ Seeking View OSIR Breaking News & Analysis - Seeking Alpha
Spotlight View OSIR Annual Report - CompanySpotlight.com OTC Report View OSIR OTC Short Report - OTCShortReport.com
TradeKing View OSIR Fundamentals - TradeKing Charts View OSIR SEC Filings - Bar Chart
WSJ View Historical Prices for OSIR - The WSJ Morningstar View Performance/Total Return for OSIR - Morningstar
MarketWatch View the Analyst Estimates for OSIR - MarketWatch CNBC View the Earnings History for OSIR - CNBC
StockMarketWatch View the OSIR Earnings - StockMarketWatch MacroAxis View OSIR Buy or Sell Recommendations - MacroAxis
Bullish View the OSIR Bullish Patterns - American Bulls Short Pains View OSIR Short Pain Metrics - ShortPainBot.com


Social Media Mentions

StockTwits View OSIR Stock Mentions - StockTwits PennyStocks View OSIR Stock Mentions - PennyStockTweets
Twitter View OSIR Stock Mentions - Twitter Invest Hub View OSIR Investment Forum News - Investor Hub
Yahoo View OSIR Stock Mentions - Yahoo! Message Board Seeking Alpha View OSIR Stock Mentions - Seeking Alpha






Financial & Transaction Holdings

SECform4 View Insider Transactions for OSIR - SECform4.com Insider Cow View Insider Transactions for OSIR - Insider Cow
CNBC View OSIR Major Holdings Summary - CNBC OTC Markets View Insider Disclosure for OSIR - OTC Markets
Yahoo View Insider Transactions for OSIR - Yahoo! Finance NASDAQ View Institutional Holdings for OSIR - NASDAQ


Stock Charts

FinViz View OSIR Stock Insight & Charts - FinViz.com StockCharts View OSIR Investment Charts - StockCharts.com
BarChart View OSIR Stock Overview & Charts - BarChart Trading View View OSIR User Generated Charts - Trading View


Latest Financial News for OSIR

Osiris Announces Implementation of Prestige Lyotechnology℠ Preservation Method Allowing Ambient Storage of Living Tissues
Posted on Monday June 04, 2018

Osiris Therapeutics, Inc. (OTC Pink:OSIR), a regenerative medicine company focused on developing and marketing products for wound care, orthopedics, and sports medicine, announced today the implementation of Prestige Lyotechnology for manufacturing of commercial products. In 2017, Osiris announced the development of Prestige Lyotechnology, a preservation technique for ambient storage of living tissues (see http://www.osiris.com/wp-content/uploads/2017/03/2017-03-30-Prestige-Lyo-Nature-article-PR-FINAL.pdf).


Osiris Announces New Peer-Reviewed Publication Summarizing Clinical Outcomes of Viable Cryopreserved Placental Membranes for Management of Chronic Diabetic Foot Ulcers in Real World Setting
Posted on Wednesday April 25, 2018

In a prior multicenter, randomized, controlled clinical trial (RCT), application of our viable cryopreserved placental membrane product, Grafix®, to chronic diabetic foot ulcers (DFUs) resulted in a significantly higher proportion of wound closure by 12 weeks compared to control (62% vs. 21%)1.  Although RCTs remain the gold standard to determine treatment efficacy, RCT results may not accurately reflect the effectiveness of therapies in real-world practice. Results in effectiveness studies may differ from results observed in tightly controlled experimental conditions of an efficacy study, as broader populations of patients and clinicians have access to products.


Osiris Therapeutics to Present Clinical and Scientific Studies at Symposium on Advanced Wound Care and Wound Healing Society Spring Conference
Posted on Tuesday April 24, 2018

COLUMBIA, Maryland, April 24, 2018-- Osiris Therapeutics, Inc., a leading regenerative medicine company focused on developing and marketing products for wound care, orthopedics, and sports medicine, will ...


Update in Lawsuit for Investors in Osiris Therapeutics, Inc. (NASDAQ: OSIR) Shares Announced by Shareholders Foundation
Posted on Tuesday November 28, 2017

SAN DIEGO, CA / ACCESSWIRE / November 28, 2017 / The Shareholders Foundation, Inc. announces that a lawsuit is pending for certain investors who purchased NASDAQ: OSIR shares against Osiris Therapeutics, ...


Enter a stock symbol to view the stock details.